Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren’s syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?
Sofie L M Blokland, Maarten R Hillen, Catharina G K Wichers, Maili Zimmermann, Aike A Kruize, Timothy R D J Radstake, Jasper C A Broen, Joel A G van Roon
RMD Open Jan 2019, 5 (1) e000701; DOI: 10.1136/rmdopen-2018-000701